ATUL2021-01-012021-03-31in-bse-fin:OneOperatingExpenses01Member ATUL2021-01-012021-03-31in-bse-fin:OneOperatingExpenses02Member ATUL2021-01-012021-03-31in-bse-fin:FourOperatingExpenses01Member ATUL2021-01-012021-03-31in-bse-fin:FourOperatingExpenses02Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentRevenue01Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentRevenue02Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentRevenue03Member ATUL2021-01-012021-03-31in-bse-fin:FourReportableSegmentRevenue01Member ATUL2021-01-012021-03-31in-bse-fin:FourReportableSegmentRevenue02Member ATUL2021-01-012021-03-31in-bse-fin:FourReportableSegmentRevenue03Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentResults01Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentResults02Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentResults03Member ATUL2021-01-012021-03-31in-bse-fin:FourReportableSegmentResults01Member ATUL2021-01-012021-03-31in-bse-fin:FourReportableSegmentResults02Member ATUL2021-01-012021-03-31in-bse-fin:FourReportableSegmentResults03Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentAssets01Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentAssets02Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentAssets03Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentLiabilities01Member ATUL2021-03-31in-bse-fin:OneReportableSegmentLiabilities01Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentLiabilities02Member ATUL2021-03-31in-bse-fin:OneReportableSegmentLiabilities02Member ATUL2021-01-012021-03-31in-bse-fin:OneReportableSegmentLiabilities03Member ATUL2021-03-31in-bse-fin:OneReportableSegmentLiabilities03Member ATUL2021-01-012021-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ATUL2021-01-012021-03-31in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ATUL2021-01-012021-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member ATUL2021-01-012021-03-31in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss02Member ATUL2021-01-012021-03-31in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member ATUL2021-01-012021-03-31in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares ATUL 2020-04-01 2021-03-31 2021-03-31 INR Crores Yearly true Cash Flow Indirect Multi segment 2021-01-01 2021-03-31 Unaudited Standalone 10780100000.00 158200000.00 10938300000.00 5026600000.00 405200000.00 -255200000.00 643000000.00 5100000.00 315900000.00 2538700000.00 8679300000.00 2259000000.00 0.00 2259000000.00 541300000.00 25900000.00 567200000.00 0.00 1691800000.00 0.00 0.00 0.00 0.00 1691800000.00 -376900000.00 1314900000.00 0.00 0.00 295900000.00 10 57.06 57.06 0.00 0.00 57.06 57.06 0.00 0.00 0.00 Standalone financial results for the quarter / year ended on March 31, 2021 Notes: 1. These results have been prepared in accordance with the Indian Accounting Standard (Ind AS) notified under the Companies (Indian Accounting Standards) Rules, 2015 as amended from time to time. 2. These results have been reviewed and recommended for adoption by the Audit Committee in its meeting held on April 29, 2021, and approved by the Board of Directors in its meeting held on April 30, 2021 through video conferencing. The Statutory Auditors report does not have any qualification / modification. 3. The Company publishes standalone financial results along with the consolidated financial results. In accordance with the Ind AS 108, 'Operating Segments', the Company has disclosed the segment information in the consolidated financial results and therefore no separate disclosure on segment information is given in the standalone financial results for the quarter / year ended on March 31, 2021. 4. Following items are included in other income: (` cr) No. Particulars Quarter ended on Year ended on March 31, 2021 December 31, 2020 March 31, 2020 March 31, 2021 March 31, 2020 Unaudited Unaudited Unaudited Unaudited Audited a) Exchange rate difference - gain / (loss) 1.07 (2.02) 12.43 (7.52) 18.59 b) Dividend - 24.37 8.24 58.03 23.09 5. Manufacturing facilities of the Company which were shutdown in the last week of March 2020 due to countrywide lockdown, resumed operations in a phased manner from the last week of April 2020 after obtaining the requisite approvals. The Company has considered possible effects that may result from COVID-19 in preparation of these standalone financial results including recoverability of inventories, trade receivables and other assets. In developing the assumptions relating to future uncertainties in the economic conditions due to COVID-19, it has, at the date of approval of these standalone financial results, used relevant internal and external sources of information including economic forecasts and expects that the carrying amounts of these assets are recoverable. The impact of COVID-19, including the current wave, may be different from that estimated as at the date of approval of these standalone financial results. 6. The Parliament of India has approved the Code on Social Security, 2020 (the Code) which may impact the contributions by the Company towards provident fund, gratuity and ESIC. The Ministry of Labour and Employment has released draft rules for the Code on November 13, 2020. Final rules are yet to be notified. The Company will assess the impact of the Code when it comes into effect and will record related impact, if any. Multi segment 2020-04-01 2021-03-31 Audited Standalone 35123500000.00 1037100000.00 36160600000.00 15250100000.00 1397300000.00 -633100000.00 2491000000.00 19700000.00 1202300000.00 8155800000.00 27883100000.00 8277500000.00 0.00 8277500000.00 1991900000.00 -23300000.00 1968600000.00 0.00 6308900000.00 0.00 0.00 0.00 0.00 6308900000.00 702000000.00 7010900000.00 0.00 0.00 295900000.00 10 0.00 212.78 212.78 0.00 0.00 212.78 212.78 0.00 0.00 0.00 Other Expenses 1656600000.00 Power Fuel and water 882100000.00 Other Expenses 5150000000.00 Power Fuel and water 3005800000.00 Life Science Chemicals 3118900000.00 Others 149300000.00 Performance and Other Chemicals 8171600000.00 Life Science Chemicals 12163700000.00 Others 484800000.00 Performance and Other Chemicals 26218800000.00 11439800000.00 38867300000.00 280500000.00 1552600000.00 11159300000.00 37314700000.00 Life Science Chemicals 506400000.00 Others 45200000.00 Performance and Other Chemicals 1832100000.00 Life Science Chemicals 2195700000.00 Others 113000000.00 Performance and Other Chemicals 5941600000.00 2383700000.00 8250300000.00 22500000.00 -566500000.00 2361200000.00 8816800000.00 Life Science Chemicals 8432000000.00 Others 1308300000.00 Performance and Other Chemicals 19917000000.00 29657300000.00 19714700000.00 49372000000.00 Life Science Chemicals 2907100000.00 Others 373800000.00 Performance and Other Chemicals 5793200000.00 9074100000.00 1726400000.00 10800500000.00 19700000.00 -831100000.00 -115900000.00 0.00 118300000.00 0.00 0.00 0.00 0.00 877200000.00 0.00 -44900000.00 0.00 1202300000.00 0.00 48100000.00 0.00 0.00 0.00 113200000.00 580300000.00 146000000.00 0.00 -231600000.00 0.00 0.00 0.00 22600000.00 0.00 451600000.00 8729100000.00 0.00 0.00 0.00 1964000000.00 0.00 6765100000.00 0.00 36600000.00 0.00 991700000.00 0.00 0.00 0.00 0.00 9700000.00 2706900000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 10000000.00 0.00 0.00 0.00 0.00 133500000.00 0.00 0.00 0.00 601800000.00 35900000.00 0.00 -2798500000.00 0.00 -6029800000.00 0.00 0.00 0.00 0.00 617400000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19700000.00 0.00 0.00 -637100000.00 98200000.00 0.00 98200000.00 54300000.00 152500000.00